Aravive, Inc.
ARAV · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.04 | 0.09 | -0.11 | 0.09 |
| FCF Yield | -135.57% | -73.21% | -13.66% | -10.78% |
| EV / EBITDA | -0.01 | 0.22 | -1.93 | -5.68 |
| Quality | ||||
| ROIC | -171.43% | -77.81% | -58.84% | -29.54% |
| Gross Margin | -632.60% | -404.45% | -209.94% | -170.06% |
| Cash Conversion Ratio | 0.85 | 0.82 | 0.40 | 0.94 |
| Growth | ||||
| Revenue 3-Year CAGR | 17.14% | 16.12% | 60.66% | -50.84% |
| Free Cash Flow Growth | -102.29% | -164.42% | 28.76% | 45.54% |
| Safety | ||||
| Net Debt / EBITDA | 0.67 | 1.31 | 2.71 | 3.01 |
| Interest Coverage | -15.40 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | -34.85 | -40.67 | 8.19 | -102.69 |
| Cash Conversion Cycle | -54.87 | -33.19 | 9.61 | 115.54 |